BayBridge Capital Group LLC Boosts Stake in HCA Healthcare, Inc. (NYSE:HCA)

BayBridge Capital Group LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 1.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,485 shares of the company’s stock after purchasing an additional 35 shares during the quarter. HCA Healthcare makes up 1.0% of BayBridge Capital Group LLC’s portfolio, making the stock its 23rd biggest position. BayBridge Capital Group LLC’s holdings in HCA Healthcare were worth $1,416,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Bangor Savings Bank boosted its holdings in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. MFA Wealth Advisors LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC bought a new position in HCA Healthcare in the 2nd quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare during the second quarter valued at $33,000. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,345 shares of company stock worth $5,747,945. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Royal Bank of Canada upped their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Leerink Partners lifted their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. UBS Group raised their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Deutsche Bank Aktiengesellschaft raised their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Finally, Truist Financial upped their price objective on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Five investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and four have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $377.17.

HCA Healthcare Trading Down 8.8 %

HCA Healthcare stock opened at $363.75 on Friday. The stock has a market cap of $95.27 billion, a P/E ratio of 18.13, a PEG ratio of 1.44 and a beta of 1.67. The firm’s 50 day moving average price is $395.26 and its 200-day moving average price is $352.63. HCA Healthcare, Inc. has a 1 year low of $220.55 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. During the same quarter last year, the business posted $4.29 earnings per share. The business’s quarterly revenue was up 10.3% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.73%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.